Daxor Corporation Announces a 38 Percent Rise in BVA-100 Cardiology Kit Sales and Net Gain of $498,111 for Six Months in Filing of Form N-CSR for June 30, 2019
September 04, 2019 08:00 ET
|
Daxor Corporation
NEW YORK, Sept. 04, 2019 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR) an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume...
Daxor Corporation Announces the Acquisition of the BVA-100® Blood Volume Analyzer by a Leading Academic Health Center in the Pacific Northwest
August 06, 2019 08:00 ET
|
Daxor Corporation
NEW YORK, Aug. 06, 2019 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume...
Daxor Corporation Announces New Research Initiative with Leading Hospital in the Southeast and the BVA-100® Blood Volume Diagnostic Test
June 18, 2019 08:00 ET
|
Daxor Corporation
NEW YORK, June 18, 2019 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume...
Daxor Corporation to Present at the LD Micro 9th Annual Invitational on June 4th, 2019
May 31, 2019 08:00 ET
|
Daxor Corporation
NEW YORK, May 31, 2019 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume...
Daxor Corporation Announces New Partnership with Leading Hospital in North Carolina to Integrate the BVA-100® Blood Volume Analyzer Diagnostic Test as Part of Standard Clinical Practice
May 30, 2019 08:00 ET
|
Daxor Corporation
NEW YORK, May 30, 2019 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume...
Daxor Corporation to Exhibit at the Society of Hospital Medicine (SHM) Annual Conference 2019
March 22, 2019 08:30 ET
|
Daxor Corporation
NEW YORK , March 22, 2019 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR) an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume...
Daxor Corporation Addresses and Corrects Erroneous Seeking Alpha Healthcare News Editor Article of March 20, 2019
March 21, 2019 08:30 ET
|
Daxor Corporation
Author incorrectly claimed, “The company's sole product is a blood volume analyzer called the BVA-100 but there does not appear to be any sales to date.” NEW YORK, March 21, 2019 (GLOBE NEWSWIRE)...
Daxor Corporation to Present at the 31st Annual Roth Conference on March 19, 2019
March 15, 2019 08:30 ET
|
Daxor Corporation
NEW YORK, March 15, 2019 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR) an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume...
Daxor Corporation to Showcase Reduction in Mortality and Hospital Readmissions with BVA-100® Guided-Care at the Annual Meeting of the American College of Cardiology Expo 2019
March 13, 2019 08:30 ET
|
Daxor Corporation
NEW YORK, March 13, 2019 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR) an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume...
Daxor Corporation Announces Rise in Kit Sales and Files Form N-CSR For 2018
March 04, 2019 08:30 ET
|
Daxor Corporation
NEW YORK, March 04, 2019 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR) an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume...